filings.toolsItem 8. Financial Statements and Supplementary Data
123K characters. Original on sec.gov · Markdown
Item 8. Financial Statements and Supplementary Data
CONSOLIDATED FINANCIAL STATEMENTS
Garmin Ltd. and Subsidiaries
Years Ended December 30, 2023, December 31, 2022, and December 25, 2021
Contents
Report of Independent Regist****ered Public Accounting Firm
To the Shareholders and the Board of Directors of Garmin Ltd. and Subsidiaries
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Garmin Ltd. and Subsidiaries (the Company) as of December 30, 2023 and December 31, 2022, the related consolidated statements of income, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 30, 2023, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 30, 2023 and December 31, 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 30, 2023, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 30, 2023, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 21, 2024, expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Measurement of Reserve for Unrecognized Income Tax Benefits
| Description of the Matter | The Company accounts for uncertainty in income taxes in accordance with the FASB ASC 740 topic, Income Taxes. The Company operates in a multinational tax environment and is subject to tax laws, regulations and guidelines for intercompany transactions that have transfer pricing subjectivity. The Company uses significant judgment to evaluate uncertain tax positions and determine whether the threshold for recognition has been met and to measure the largest amount of benefit that is more likely than not to be realized upon ultimate settlement. As discussed in Note 5 to the consolidated financial statements, the Company’s balance of gross unrecognized income tax benefits was $14 million at December 30, 2023, primarily related to transfer pricing positions. Auditing management’s assessment and measurement of material tax positions is complex and involved especially subjective and complex judgments. The assessment process involves both significant judgment to evaluate each position against the recognition threshold and estimation because the pricing of the intercompany transactions is based on pricing analyses that may produce a number of different outcomes or ranges of outcomes (e.g., the price that would be charged in an arm’s-length transaction). Each transfer pricing tax position carries unique facts and circumstances that must be evaluated, and ultimate resolution will be dependent on uncontrollable factors, such as the interpretation of laws and regulations; new case law; the willingness of the income tax authority to settle the issue, including the timing thereof; and other factors. |
| How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of controls that address the risks of material misstatement relating to the identification, assessment, measurement and valuation of uncertain tax positions related to transfer pricing from intercompany transactions. For example, we tested controls over management’s review of intercompany transfer pricing positions against the measurement criteria, review of inputs and calculations of these uncertain tax positions, which included management’s evaluation of the ranges of outcomes and pricing conclusions reached within the transfer pricing studies. Our audit procedures included, among others, involving our tax professionals to test the Company’s assessment and measurement of tax positions related to transfer pricing used in intercompany transactions to assess the appropriateness of the ranges of outcomes utilized, the determination of the likelihood of the outcomes, and any related pricing or valuation conclusions reached within the transfer pricing analyses conducted by the Company. For example, we compared the transfer pricing methodology utilized by management to alternative methodologies and industry benchmarks. We also verified our understanding of the relevant facts by reading the Company’s correspondence with the relevant tax authorities and any third-party advice obtained by the Company. In addition, we used our knowledge of international and local income tax laws, as well as historical settlement activity from income tax authorities, to evaluate the appropriateness of the Company’s measurement of uncertain tax positions related to transfer pricing used in these intercompany transactions. |
/s/ Ernst & Young LLP
We have served as the Company’s auditor since 1990.
Kansas City, Missouri
February 21, 2024
| Garmin Ltd. and Subsidiaries | ||||||||||||
| Consolidated Statements of Income | ||||||||||||
| (In thousands, except per share information) | ||||||||||||
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Net sales | $ | 5,228,252 | $ | 4,860,286 | $ | 4,982,795 | ||||||
| Cost of goods sold | 2,223,297 | 2,053,511 | 2,092,336 | |||||||||
| Gross profit | 3,004,955 | 2,806,775 | 2,890,459 | |||||||||
| Advertising expense | 173,109 | 168,040 | 171,829 | |||||||||
| Selling, general and administrative expenses | 834,990 | 775,963 | 721,260 | |||||||||
| Research and development expense | 904,696 | 834,927 | 778,750 | |||||||||
| Total operating expense | 1,912,795 | 1,778,930 | 1,671,839 | |||||||||
| Operating income | 1,092,160 | 1,027,845 | 1,218,620 | |||||||||
| Other income (expense): | ||||||||||||
| Interest income | 77,302 | 40,826 | 28,573 | |||||||||
| Foreign currency gains (losses) | 26,434 | (11,274 | ) | (45,263 | ) | |||||||
| Other income | 4,460 | 7,577 | 4,866 | |||||||||
| Total other income (expense) | 108,196 | 37,129 | (11,824 | ) | ||||||||
| Income before income taxes | 1,200,356 | 1,064,974 | 1,206,796 | |||||||||
| Income tax provision (benefit): | ||||||||||||
| Current | 250,446 | 233,844 | 130,040 | |||||||||
| Deferred | (339,726 | ) | (142,455 | ) | (5,444 | ) | ||||||
| Total income tax provision (benefit) | (89,280 | ) | 91,389 | 124,596 | ||||||||
| Net income | $ | 1,289,636 | $ | 973,585 | $ | 1,082,200 | ||||||
| Basic net income per share | $ | 6.74 | $ | 5.06 | $ | 5.63 | ||||||
| Diluted net income per share | $ | 6.71 | $ | 5.04 | $ | 5.61 | ||||||
| See accompanying notes. |
| Garmin Ltd. and Subsidiaries | ||||||||||||
| Consolidated Statements of Comprehensive Income | ||||||||||||
| (In thousands) | ||||||||||||
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Net income | $ | 1,289,636 | $ | 973,585 | $ | 1,082,200 | ||||||
| Foreign currency translation adjustment | 14,473 | (149,396 | ) | (39,538 | ) | |||||||
| Change in fair value of available-for-sale marketable securities, net of deferred taxes | 34,446 | (82,972 | ) | (26,054 | ) | |||||||
| Comprehensive income | $ | 1,338,555 | $ | 741,217 | $ | 1,016,608 | ||||||
| See accompanying notes. |
| Garmin Ltd. and Subsidiaries | ||||||||
| Consolidated Balance Sheets | ||||||||
| (In thousands) | ||||||||
| December 30, 2023 | December 31, 2022 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 1,693,452 | $ | 1,279,194 | ||||
| Marketable securities | 274,618 | 173,288 | ||||||
| Accounts receivable, less allowance for doubtful accounts of $7,152 in 2023 and $5,098 in 2022 | 815,243 | 656,847 | ||||||
| Inventories | 1,345,955 | 1,515,045 | ||||||
| Deferred costs | 16,316 | 14,862 | ||||||
| Prepaid expenses and other current assets | 318,556 | 315,915 | ||||||
| Total current assets | 4,464,140 | 3,955,151 | ||||||
| Property and equipment, net | 1,224,097 | 1,147,005 | ||||||
| Operating lease right-of-use assets | 143,724 | 138,040 | ||||||
| Noncurrent marketable securities | 1,125,191 | 1,208,360 | ||||||
| Deferred income tax assets | 754,635 | 441,071 | ||||||
| Noncurrent deferred costs | 11,057 | 9,831 | ||||||
| Goodwill | 608,474 | 567,994 | ||||||
| Other intangible assets, net | 186,601 | 178,461 | ||||||
| Other noncurrent assets | 85,650 | 85,257 | ||||||
| Total assets | $ | 8,603,569 | $ | 7,731,170 | ||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 253,790 | $ | 212,417 | ||||
| Salaries and benefits payable | 190,014 | 176,114 | ||||||
| Accrued warranty costs | 55,738 | 50,952 | ||||||
| Accrued sales program costs | 98,610 | 97,772 | ||||||
| Other accrued expenses | 245,874 | 197,376 | ||||||
| Deferred revenue | 101,189 | 91,092 | ||||||
| Income taxes payable | 225,475 | 246,180 | ||||||
| Dividend payable | 139,997 | 139,732 | ||||||
| Total current liabilities | 1,310,687 | 1,211,635 | ||||||
| Deferred income tax liabilities | 114,682 | 129,965 | ||||||
| Noncurrent income taxes payable | 16,521 | 34,627 | ||||||
| Noncurrent deferred revenue | 36,148 | 35,702 | ||||||
| Noncurrent operating lease liabilities | 113,035 | 114,541 | ||||||
| Other noncurrent liabilities | 436 | 360 | ||||||
| Stockholders’ equity: | ||||||||
| Common shares (195,880 and 198,077 shares authorized and issued;191,777 and 191,623 shares outstanding) | 19,588 | 17,979 | ||||||
| Additional paid-in capital | 2,125,467 | 2,042,472 | ||||||
| Treasury shares (4,103 and 6,454 shares) | (330,909 | ) | (475,095 | ) | ||||
| Retained earnings | 5,263,528 | 4,733,517 | ||||||
| Accumulated other comprehensive income (loss) | (65,614 | ) | (114,533 | ) | ||||
| Total stockholders’ equity | 7,012,060 | 6,204,340 | ||||||
| Total liabilities and stockholders’ equity | $ | 8,603,569 | $ | 7,731,170 | ||||
| See accompanying notes. |
| Garmin Ltd. and Subsidiaries | ||||||||||||
| Consolidated Statements of Cash Flows | ||||||||||||
| (In thousands) | ||||||||||||
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Operating Activities: | ||||||||||||
| Net income | $ | 1,289,636 | $ | 973,585 | $ | 1,082,200 | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation | 132,347 | 118,743 | 103,498 | |||||||||
| Amortization | 45,225 | 45,110 | 51,320 | |||||||||
| Loss (gain) on sale of property and equipment | 215 | (2,083 | ) | 298 | ||||||||
| Unrealized foreign currency (gains) losses | (25,541 | ) | (5,867 | ) | 36,385 | |||||||
| Deferred income taxes | (340,774 | ) | (143,286 | ) | (5,368 | ) | ||||||
| Stock compensation expense | 101,422 | 76,801 | 92,522 | |||||||||
| Realized losses (gains) on marketable securities | 62 | 986 | (622 | ) | ||||||||
| Changes in operating assets and liabilities, net of acquisitions: | ||||||||||||
| Accounts receivable, net of allowance for doubtful accounts | (129,120 | ) | 167,336 | (19,106 | ) | |||||||
| Inventories | 244,506 | (363,327 | ) | (476,454 | ) | |||||||
| Other current and noncurrent assets | 7,887 | 72,185 | (38,004 | ) | ||||||||
| Accounts payable | 28,503 | (131,268 | ) | 108,946 | ||||||||
| Other current and noncurrent liabilities | 52,188 | (71,756 | ) | 70,007 | ||||||||
| Deferred revenue | 10,411 | (2,379 | ) | (7,377 | ) | |||||||
| Deferred costs | (2,661 | ) | 3,591 | 8,288 | ||||||||
| Income taxes | (38,041 | ) | 49,888 | 5,894 | ||||||||
| Net cash provided by operating activities | 1,376,265 | 788,259 | 1,012,427 | |||||||||
| Investing activities: | ||||||||||||
| Purchases of property and equipment | (193,524 | ) | (244,286 | ) | (307,645 | ) | ||||||
| Proceeds from sale of property and equipment | 218 | 2,402 | 35 | |||||||||
| Purchase of intangible assets | (1,504 | ) | (1,907 | ) | (1,942 | ) | ||||||
| Purchase of marketable securities | (170,681 | ) | (1,051,994 | ) | (1,508,712 | ) | ||||||
| Redemption of marketable securities | 183,372 | 1,164,116 | 1,363,070 | |||||||||
| Acquisitions, net of cash acquired | (150,853 | ) | (13,455 | ) | (20,175 | ) | ||||||
| Net cash used in investing activities | (332,972 | ) | (145,124 | ) | (475,369 | ) | ||||||
| Financing activities: | ||||||||||||
| Dividends | (558,769 | ) | (679,096 | ) | (491,457 | ) | ||||||
| Proceeds from issuance of treasury shares related to equity awards | 44,063 | 62,221 | 35,733 | |||||||||
| Purchase of treasury shares related to equity awards | (22,815 | ) | (22,730 | ) | (30,985 | ) | ||||||
| Purchase of treasury shares under share repurchase plan | (98,988 | ) | (201,012 | ) | — | |||||||
| Net cash used in financing activities | (636,509 | ) | (840,617 | ) | (486,709 | ) | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 7,460 | (21,449 | ) | (10,254 | ) | |||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 414,244 | (218,931 | ) | 40,095 | ||||||||
| Cash, cash equivalents, and restricted cash at beginning of year | 1,279,912 | 1,498,843 | 1,458,748 | |||||||||
| Cash, cash equivalents, and restricted cash at end of year | $ | 1,694,156 | $ | 1,279,912 | $ | 1,498,843 | ||||||
| See accompanying notes. |
| Garmin Ltd. and Subsidiaries | ||||||||||||
| Consolidated Statements of Cash Flows (continued) | ||||||||||||
| (In thousands) | ||||||||||||
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Supplemental disclosures of cash flow information | ||||||||||||
| Cash paid during the year for income taxes | $ | 302,154 | $ | 184,809 | $ | 131,040 | ||||||
| Cash received during the year from income tax refunds | $ | 12,133 | $ | 7,786 | $ | 8,264 | ||||||
| Supplemental disclosure of non-cash investing and financing activities | ||||||||||||
| (Decrease) increase in accrued capital expenditures related to purchases of property and equipment | $ | (634 | ) | $ | (4,320 | ) | $ | 9,541 | ||||
| Change in marketable securities related to unrealized appreciation (depreciation) | $ | 45,506 | $ | (107,362 | ) | $ | (32,622 | ) | ||||
| Fair value of assets acquired | $ | 189,341 | $ | 15,340 | $ | 20,956 | ||||||
| Liabilities assumed | (37,436 | ) | (1,624 | ) | (764 | ) | ||||||
| Less: cash acquired | (1,052 | ) | (261 | ) | (17 | ) | ||||||
| Cash paid for acquisitions, net of cash acquired | $ | 150,853 | $ | 13,455 | $ | 20,175 |
See accompanying notes.
| Garmin Ltd. and Subsidiaries | ||||||||||||||||||||||||
| Consolidated Statements of Stockholders' Equity | ||||||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||
| Common Shares | Additional Paid-In Capital | Treasury Shares | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total | |||||||||||||||||||
| Balance at December 26, 2020 | $ | 17,979 | $ | 1,880,354 | $ | (320,016 | ) | $ | 3,754,372 | $ | 183,427 | $ | 5,516,116 | |||||||||||
| Net income | — | — | — | 1,082,200 | — | 1,082,200 | ||||||||||||||||||
| Translation adjustment | — | — | — | — | (39,538 | ) | (39,538 | ) | ||||||||||||||||
| Adjustment related to unrealized gains (losses) on available-for-sale securities net of income tax effects of $6,568 | — | — | — | — | (26,054 | ) | (26,054 | ) | ||||||||||||||||
| Comprehensive income | 1,016,608 | |||||||||||||||||||||||
| Dividends | — | — | — | (515,835 | ) | — | (515,835 | ) | ||||||||||||||||
| Issuance of treasury shares related to equity awards | — | (12,154 | ) | 47,887 | — | — | 35,733 | |||||||||||||||||
| Stock compensation | — | 92,522 | — | — | — | 92,522 | ||||||||||||||||||
| Purchase of treasury shares related to equity awards | — | — | (30,985 | ) | — | — | (30,985 | ) | ||||||||||||||||
| Balance at December 25, 2021 | $ | 17,979 | $ | 1,960,722 | $ | (303,114 | ) | $ | 4,320,737 | $ | 117,835 | $ | 6,114,159 | |||||||||||
| Net income | — | — | — | 973,585 | — | 973,585 | ||||||||||||||||||
| Translation adjustment | — | — | — | — | (149,396 | ) | (149,396 | ) | ||||||||||||||||
| Adjustment related to unrealized gains (losses) on available-for-sale securities net of income tax effects of $24,390 | — | — | — | — | (82,972 | ) | (82,972 | ) | ||||||||||||||||
| Comprehensive income | 741,217 | |||||||||||||||||||||||
| Dividends | — | — | — | (560,805 | ) | — | (560,805 | ) | ||||||||||||||||
| Issuance of treasury shares related to equity awards | — | 4,949 | 57,272 | — | — | 62,221 | ||||||||||||||||||
| Stock compensation | — | 76,801 | — | — | — | 76,801 | ||||||||||||||||||
| Purchase of treasury shares related to equity awards | — | — | (22,730 | ) | — | — | (22,730 | ) | ||||||||||||||||
| Purchase of treasury shares under share repurchase plan, including any associated excise tax | — | — | (206,523 | ) | — | — | (206,523 | ) | ||||||||||||||||
| Balance at December 31, 2022 | $ | 17,979 | $ | 2,042,472 | $ | (475,095 | ) | $ | 4,733,517 | $ | (114,533 | ) | $ | 6,204,340 | ||||||||||
| Net income | — | — | — | 1,289,636 | — | 1,289,636 | ||||||||||||||||||
| Translation adjustment | — | — | — | — | 14,473 | 14,473 | ||||||||||||||||||
| Adjustment related to unrealized gains (losses) on available-for-sale securities net of income tax effects of $11,060 | — | — | — | — | 34,446 | 34,446 | ||||||||||||||||||
| Comprehensive income | 1,338,555 | |||||||||||||||||||||||
| Dividends | — | — | — | (559,036 | ) | — | (559,036 | ) | ||||||||||||||||
| Issuance of treasury shares related to equity awards | — | (16,580 | ) | 60,643 | — | — | 44,063 | |||||||||||||||||
| Stock compensation | — | 101,422 | — | — | — | 101,422 | ||||||||||||||||||
| Purchase of treasury shares related to equity awards | — | — | (22,815 | ) | — | — | (22,815 | ) | ||||||||||||||||
| Purchase of treasury shares under share repurchase plan, including any associated excise tax | — | — | (94,469 | ) | — | — | (94,469 | ) | ||||||||||||||||
| Cancellation of treasury shares | (238 | ) | — | 200,827 | (200,589 | ) | — | — | ||||||||||||||||
| Share capital currency change | 1,847 | (1,847 | ) | — | — | — | — | |||||||||||||||||
| Balance at December 30, 2023 | $ | 19,588 | $ | 2,125,467 | $ | (330,909 | ) | $ | 5,263,528 | $ | (65,614 | ) | $ | 7,012,060 | ||||||||||
| See accompanying notes. |
Garmin Ltd. and Subsidiaries
Notes to Consolidated Financial Statements
(In thousands, except share and per share information)
December 30, 2023 and December 31, 2022
1. Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
Garmin Ltd. and its subsidiaries (collectively, the Company or Garmin) design, develop, manufacture, market, and distribute a diverse family of hand-held, wrist-based, portable, and fixed-mount Global Positioning System (GPS)-enabled products and other navigation, communications, information and sensor-based products and services. Garmin Corporation (GC) is primarily responsible for the manufacturing and distribution of the Company’s products to the Company’s subsidiaries and, to a lesser extent, new product development and sales and marketing of the Company’s products in Asia and the Far East. Garmin International, Inc. (GII) is primarily responsible for sales and marketing of the Company’s products in the Americas region and for most of the Company’s research and new product development. GII also manufactures most of the Company’s products in the aviation segment. Garmin (Europe) Ltd. (GEL) is primarily responsible for sales and marketing of the Company’s products in Europe, the Middle East and Africa (EMEA). Many of GEL’s sales are to other Company-owned distributors in the EMEA region.
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The accompanying consolidated financial statements reflect the accounts of Garmin Ltd. and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated.
Changes in Classification and Allocation
Certain prior period amounts have been recast, reclassified, or presented to conform to current period presentation.
The Company announced an organization realignment in January 2023, which combined the consumer auto operating segment with the outdoor operating segment. As a result, the Company’s operating segments, which also represent its reportable segments, are fitness, outdoor, aviation, marine, and auto OEM. Results for the 53-week and 52-week periods ended December 31, 2022 and December 25, 2021, respectively, have been recast to conform to current period presentation. This change had no effect on the Company’s consolidated results of operations.
Fiscal Year
The Company’s fiscal year is based on a 52-53-week period ending on the last Saturday of the calendar year. Due to the fact that there are not exactly 52 weeks in a calendar year, the Company will have a fiscal year comprising 53 weeks in certain fiscal years, as determined by when the last Saturday of the calendar year occurs.
In those resulting fiscal years that have 53 weeks, the Company will record an extra week of sales, costs, and related financial activity. Therefore, the financial results of those 53-week fiscal years, and the associated 14-week fourth quarters, will not be entirely comparable to the prior and subsequent 52-week fiscal years and the associated 13-week quarters. Fiscal year 2023 contains 52 weeks compared to 53 weeks for 2022 and 52 weeks for 2021.
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Foreign Currency
Many Garmin Ltd. subsidiaries utilize currencies other than the United States Dollar (USD) as their functional currency. As required by Accounting Standards Codification (ASC) Topic 830, Foreign Currency Matters, the financial statements of these subsidiaries for all periods presented have been translated into USD, the functional currency of Garmin Ltd., and the reporting currency herein, for purposes of consolidation at rates prevailing during the year for sales, costs, and expenses and at end-of-year rates for all assets and liabilities. The effect of this translation is recorded in a separate component of stockholders’ equity. Cumulative currency translation adjustments of $(11,508) and $(25,981) as of December 30, 2023 and December 31, 2022, respectively, have been included in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets.
Transactions in foreign currencies are recorded at the approximate rate of exchange at the transaction date. Assets and liabilities resulting from these transactions are translated at the rate of exchange in effect at the balance sheet date. The majority of the Company’s consolidated foreign currency gain or loss is typically driven by the significant cash and marketable securities, receivables, and payables held in a currency other than the functional currency at a given legal entity. Net foreign currency gains recorded in results of operations were $26,434 for the year ended December 30, 2023, net foreign currency losses recorded in results of operations were $11,274 for the year ended December 31, 2022, and net foreign currency losses recorded in results of operations were $45,263 for the year ended December 25, 2021. The gain in fiscal 2023 was primarily due to the U.S. Dollar weakening against the Polish Zloty and Euro, partially offset by the U.S. Dollar strengthening against the Taiwan Dollar. The loss in fiscal 2022 was primarily due to the U.S. Dollar strengthening against the Australian Dollar, Polish Zloty, Chinese Yuan, Euro, Japanese Yen, and British Pound Sterling, partially offset by the U.S. Dollar strengthening against the Taiwan Dollar. The loss in fiscal 2021 was primarily due to the U.S. Dollar strengthening against the Euro, Polish Zloty, Japanese Yen, Swiss Franc, and Australian Dollar, while the U.S. Dollar weakened against the Taiwan Dollar.
Garmin Corporation, one of the Company’s principal subsidiaries, is located in Taiwan. The Taiwan Foreign Exchange Control Statute (the Statute), and regulations thereunder, provides that all foreign exchange transactions must be executed by banks designated to handle such business by the Ministry of Finance of Taiwan and by the Central Bank of the Republic of China (Taiwan), also referred to as the CBC. Current regulations favor trade-related foreign exchange transactions, so the Statute does not impose any significant restrictions on import or export activities involving foreign currencies in Taiwan. Non-trade related currency exchanges exceeding $50 million, or its equivalent, in a calendar year require approval of the CBC.
Revenue Recognition
The Company recognizes revenue upon the transfer of control of promised products or services to the customer in an amount that depicts the consideration to which the Company expects to be entitled for the related products or services. For the large majority of the Company’s sales, transfer of control occurs once product has shipped and title and risk of loss have transferred to the customer. The Company offers certain tangible products with ongoing services promised over a period of time. When such services have been identified as both capable of being distinct and separately identifiable from the related tangible product, the associated revenue allocated to such services is recognized over time. The Company generally does not offer specified or unspecified upgrade rights to its customers in connection with software sales.
The Company allocates revenue to all performance obligations associated with tangible products containing separately identifiable ongoing services based on the respective performance obligations’ relative standalone selling prices (SSP), with the amounts allocated to ongoing services deferred and recognized over a period of time. These ongoing services primarily consist of the Company’s contractual promises to provide personal navigation device (PND) users with map updates and server-based traffic services. In addition, the Company provides map update services (map care) over a contractual period in certain hardware and software contracts with automotive original equipment manufacturers (OEMs). The Company has determined that directly observable prices do not exist for certain map updates, map care, or server-based traffic, as stand-alone and unbundled unit sales do not occur on more than a limited basis. Therefore, the Company uses the expected cost plus a margin as the primary indicator to calculate relative SSP of certain map updates, map care, and traffic performance obligations. The revenue and associated costs allocated to map updates, map care, and server-based traffic services are deferred and recognized ratably over the contractual service period or estimated life of the products. Additionally, the Company has offered certain other products and services with ongoing performance obligations for which the associated revenue is recognized over the contractual service period (typically ranging from 1 month to 3 years), including aviation database and other service subscriptions, incremental navigation and communication service subscriptions, mobile applications, and extended warranties.
The Company records revenue net of sales tax or value-added tax and variable consideration such as trade discounts and customer returns. Payment is due typically within 90 days or less of shipment of product, or upon the grant of a given software license (as applicable). The Company records estimated reductions to revenue in the form of variable consideration for customer sales programs, returns, and incentive offerings including rebates, price protection, promotions, and other volume-based incentives. Cooperative advertising incentives payable to dealers and distributors are recorded as reductions of revenue unless the Company obtains proof of a distinct advertising service, in which case the incentive is recorded as advertising expense. The reductions to revenue are based on estimates and judgments using historical experience and expectation of future conditions, if not otherwise determinable.
Shipping and Handling Costs
Shipping and handling activities are typically performed before the customer obtains control of the good, and the related costs are expensed at the approximate time of sale. Shipping and handling costs are included in cost of goods sold in the accompanying consolidated statements of income.
Advertising Costs
The Company expenses advertising costs as incurred. Advertising expense amounted to approximately $173,109, $168,040, and $171,829 for the years ended December 30, 2023, December 31, 2022, and December 25, 2021, respectively.
Software Development Costs
ASC Topic 985-20, Software – Costs of Software to Be Sold, Leased, or Marketed, requires companies to expense software development costs as they incur them until technological feasibility has been established, at which time those costs are capitalized until the product is available for general release to customers. The Company’s capitalized software development costs are not significant, as the time elapsed from working model to release is typically short. As required by ASC Topic 730, Research and Development, costs incurred to enhance the Company's existing products or after the general release of the service using the product are expensed in the period they are incurred and included in research and development costs in the accompanying consolidated statements of income.
Accounting for Stock Compensation
The Company currently sponsors three employee stock compensation plans. ASC Topic 718, Compensation – Stock Compensation, requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors, including employee stock options and restricted stock, based on estimated fair values.
The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as stock compensation expense over the requisite service period in the Company’s consolidated statements of income.
As stock compensation expense recognized in the accompanying consolidated statements of income is based on awards ultimately expected to vest, they have been reduced for estimated forfeitures. Accounting guidance requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Forfeitures were estimated based on historical experience and management’s estimates.
Excess tax benefits or deficiencies from stock compensation are recognized in the income tax provision and are not estimated in the effective tax rate. Rather, they are recorded as discrete tax items in the period they occur. Excess income tax benefits from stock compensation arrangements are classified as a cash flow from operations.
Stock compensation plans are discussed in more detail in Note 10 of the Notes to Consolidated Financial Statements.
Research and Development
A majority of the Company’s research and development is performed in the United States. Research and development costs, which are typically expensed as incurred, amounted to approximately $904,696, $834,927, and $778,750 for the years ended December 30, 2023, December 31, 2022, and December 25, 2021, respectively.
Preproduction Costs Related to Long-Term Supply Arrangements
Preproduction design and development costs related to long-term supply arrangements are expensed as incurred, and classified as research and development, unless the customer has provided a contractual guarantee for reimbursement of such costs. Contractually reimbursable costs are capitalized as incurred in the consolidated balance sheets within prepaid expenses and other current assets if reimbursement is expected to be received within one year, or within other noncurrent assets if expected to be received beyond one year. Such capitalized costs were approximately $19,226 and $23,510 as of December 30, 2023 and December 31, 2022, respectively.
Income Taxes
The Company accounts for income taxes using the liability method in accordance with ASC Topic 740, Income Taxes. The liability method provides that deferred tax assets and liabilities are recorded based on the difference between the tax bases of assets and liabilities and their carrying amount for financial reporting purposes as measured based on the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
The Company accounts for uncertainty in income taxes in accordance with ASC Topic 740. The Company recognizes liabilities based on its estimate of whether, and the extent to which, additional taxes will be due. If payment of these amounts ultimately proves not to be required, the reversal of the liabilities results in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary. If the Company’s estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result.
Income taxes are discussed in more detail in Note 5 of the Notes to Consolidated Financial Statements.
Earnings Per Share
Basic earnings per share amounts are computed based on the weighted-average number of common shares outstanding. For purposes of diluted earnings per share, the number of shares that would be issued from the exercise of dilutive share-based compensation awards has been reduced by the number of shares that could have been purchased from the proceeds of the exercise or release at the average market price of the Company’s shares during the period the awards were outstanding. See Note 3 of the Notes to Consolidated Financial Statements.
Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents include cash on hand, operating accounts, money market funds, deposits readily convertible to known amounts of cash, and securities with maturities of three months or less when purchased. The carrying amount of cash and cash equivalents approximates fair value, given the short maturity of those instruments. Restricted cash is reported within other noncurrent assets on the consolidated balance sheets. See Note 7 of the Notes to Consolidated Financial Statements for additional information on restricted cash.
The total of the cash and cash equivalents balance and the restricted cash reported within other noncurrent assets on the consolidated balance sheets reconciles to the total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows.
Marketable Securities
Management determines the appropriate classification of marketable securities at the time of purchase and reevaluates such designation as of each balance sheet date.
All of the Company’s marketable securities were considered available-for-sale at December 30, 2023. Available-for-sale securities are stated at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) on the Company’s consolidated balance sheets. At December 30, 2023, and December 31, 2022, cumulative unrealized losses of $54,106 and $88,552, respectively, were reported in accumulated other comprehensive income (loss), net of related taxes.
The Company recognizes impairments relating to credit losses of available-for-sale securities through an allowance for credit losses and other income (expense) on the Company’s consolidated statements of income. Impairment not relating to credit losses is recorded in accumulated other comprehensive income (loss) on the Company’s consolidated balance sheets.
Testing for impairment of investments requires management judgment. The identification of potentially impaired investments, the determination of their fair value, and the assessment of whether any decline in value is relating to credit losses are the judgmental elements. The discovery of new information and the passage of time can change these judgments. Revisions of impairment judgments are made when new information becomes known, and any resulting impairment adjustments are made at that time. The economic environment and volatility of securities markets increase the difficulty of assessing investment impairment.
In making this assessment management evaluates the extent to which the fair value is less than the amortized cost basis, any change in credit rating of the security, adverse conditions specifically related to the security, failure of the issuer to make scheduled payments, and other relevant factors affecting the security. If it is determined that a credit loss exists, the amount of the credit loss is determined by comparing the present value of the expected future cash flows for the security to the amortized cost basis of the security, limited by the amount the fair value is less than the amortized cost basis.
The amortized cost of debt securities classified as available-for-sale is adjusted for amortization of premiums and accretion of discounts to maturity, or in the case of mortgage-backed securities, over the estimated life of the security. Such amortization and realized gains/losses are recorded within interest income and other income (expense), respectively, on the Company’s consolidated statements of income. The cost of securities sold is based on the specific identification method.
Marketable securities are discussed in more detail in Note 4 of the Notes to Consolidated Financial Statements.
Fair Value of Financial Instruments
As required by ASC Topic 825, Financial Instruments, the following summarizes required information about the fair value of certain financial instruments for which it is currently practicable to estimate such value. None of the financial instruments are held or issued for trading purposes. The carrying amounts and fair values of the Company’s financial instruments are as follows:
| December 30, 2023 | December 31, 2022 | |||||||||||||||
| Carrying Amount | Fair Value | Carrying Amount | Fair Value | |||||||||||||
| Cash and cash equivalents | $ | 1,693,452 | $ | 1,693,452 | $ | 1,279,194 | $ | 1,279,194 | ||||||||
| Marketable securities | $ | 1,399,809 | $ | 1,399,809 | $ | 1,381,648 | $ | 1,381,648 |
For certain of the Company’s financial instruments, including accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.
Trade Accounts Receivable
The Company sells its products to retailers, dealers, distributors, OEMs, and other customers and grants credit to certain customers based on its evaluation of the customers' financial condition. Generally, the Company does not require security when trade credit is granted to customers. The Company's trade accounts receivable are carried at net realizable value, typically are collected within 90 days, and do not bear interest. Certain customers are allowed extended terms consistent with normal industry practice. Credit losses are provided for in the Company’s consolidated financial statements and typically have been within management’s expectations. Past due receivable balances are typically written off when internal collection efforts have been unsuccessful in collecting the amount due. The Company maintains trade credit insurance to provide some security against certain losses within policy limits.
Concentration of Credit Risk
The Company’s top ten customers have contributed between 20% and 23% of net sales annually since 2021. None of the Company's customers accounted for 10% or more of consolidated net sales in the years ended December 30, 2023, and December 31, 2022. Amazon.com, Inc. and its affiliates (Amazon), a customer of the fitness, outdoor, marine, and consumer auto segments, was the Company's largest customer and accounted for approximately 10% of its consolidated net sales in the fiscal year ended December 25, 2021. No other customer accounted for 10% or more of Garmin's consolidated net sales in fiscal 2021.
Inventories
Inventories are stated at the lower of cost or net realizable value. Cost includes materials, labor, and manufacturing overhead associated with purchases and production and is determined on a first-in, first-out (FIFO) basis. The Company writes down its inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. Inventories consisted of the following:
| December 30, 2023 | December 31, 2022 | |||||||
| Raw materials | $ | 493,493 | $ | 600,858 | ||||
| Work-in-process | 160,919 | 180,873 | ||||||
| Finished goods | 691,543 | 733,314 | ||||||
| Inventories | $ | 1,345,955 | $ | 1,515,045 |
Deferred Revenues and Costs
At December 30, 2023 and December 31, 2022, the Company had deferred revenues totaling $137,337 and $126,794, respectively, and related deferred costs totaling $27,373 and $24,693, respectively.
Deferred revenue consists primarily of the transaction price allocated to performance obligations that are recognized over a period of time basis as discussed in the Revenue Recognition portion of this footnote. Billings associated with such items are typically completed upon the transfer of control of promised products or services to the customer and recorded to accounts receivable until payment is received. Deferred costs primarily refer to the license fees incurred by the Company associated with the aforementioned unsatisfied performance obligations, which are amortized over the same period as the revenue is recognized. The Company typically pays the associated license fees either monthly or quarterly in arrears, on a per item shipped or delivered basis.
The Company applies a practical expedient, as permitted within ASC Topic 340, Other Assets and Deferred Costs, to expense as incurred the incremental costs to obtain a contract when the amortization period of the asset that would have otherwise been recognized is one year or less.
Property and Equipment
Property and equipment is recorded at cost and typically depreciated using the straight-line method. The components of property and equipment were as follows and are generally depreciated over the following estimated useful lives:
| Estimated Useful Life | December 30, 2023 | December 31, 2022 | ||||||||
| Land | $ | 201,287 | $ | 193,861 | ||||||
| Building and improvements | 15 to 50 years | 934,837 | 856,722 | |||||||
| Machinery, equipment and software | 3 to 10 years | 1,118,561 | 1,001,344 | |||||||
| Total, at cost | 2,254,685 | 2,051,927 | ||||||||
| Accumulated depreciation | (1,030,588 | ) | (904,922 | ) | ||||||
| Property and equipment, net | $ | 1,224,097 | $ | 1,147,005 |
As required by ASC Topic 360, Property, Plant and Equipment, the Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset or asset group may not be fully recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. That assessment is based on the carrying amount of the asset at the date it is tested for recoverability. An impairment loss is measured as the amount by which the carrying amount of a long-lived asset exceeds its fair value. The Company did not recognize any material long-lived asset impairment charges in the fiscal years of 2023, 2022, or 2021.
Goodwill and Other Intangible Assets
The Company’s excess purchase cost over fair value of net assets acquired (goodwill) was $608,474 at December 30, 2023, and $567,994 at December 31, 2022. Each of the Company’s operating segments (fitness, outdoor, aviation, marine, and auto OEM) represents a distinct reporting unit. The Company allocates goodwill to reporting units in proportion to the expected benefit from each business combination. Changes in the carrying amount of goodwill for the years ended December 30, 2023 and December 31, 2022 are as follows:
| Fitness | Outdoor | Aviation | Marine | Auto OEM | Total | |||||||||||||||||||
| Goodwill balance as of December 25, 2021 | $ | 255,872 | $ | 178,955 | $ | 60,347 | $ | 79,906 | $ | — | $ | 575,080 | ||||||||||||
| Acquisitions | — | 2,518 | — | 7,340 | — | 9,858 | ||||||||||||||||||
| Foreign currency translation and other adjustments | (11,570 | ) | (3,129 | ) | — | (2,245 | ) | — | (16,944 | ) | ||||||||||||||
| Goodwill balance as of December 31, 2022 | $ | 244,302 | $ | 178,344 | $ | 60,347 | $ | 85,001 | $ | — | $ | 567,994 | ||||||||||||
| Acquisitions | — | — | — | 32,014 | — | 32,014 | ||||||||||||||||||
| Foreign currency translation and other adjustments | 6,078 | 1,400 | — | 988 | — | 8,466 | ||||||||||||||||||
| Goodwill balance as of December 30, 2023 | $ | 250,380 | $ | 179,744 | $ | 60,347 | $ | 118,003 | $ | — | $ | 608,474 |
ASC Topic 350, Intangibles – Goodwill and Other, requires that goodwill and intangible assets with indefinite useful lives should not be amortized but rather be assessed for impairment at least annually or sooner whenever events or changes in circumstances indicate that they may be impaired. The Company performs its annual impairment assessments of goodwill and indefinite-lived intangible assets, if any, in the fourth quarter of each year, as of the Company’s fiscal year end date, and between annual tests if an event occurs or circumstances change that would indicate it is more likely than not that they may be impaired.
ASC Topic 350 allows management to first perform a qualitative goodwill assessment by assessing the qualitative factors of relevant events and circumstances at the reporting unit level to determine if it is necessary to perform the quantitative goodwill impairment test. If factors indicate that it is more likely than not that the fair value of the reporting unit is less than the carrying amount, then the quantitative test will be performed. If the fair value of the reporting unit is less than the carrying amount, then a goodwill impairment charge will be recognized in the amount by which carrying amount exceeds fair value, limited to the total amount of goodwill allocated to that reporting unit.
Application of the goodwill impairment test requires judgment, including the identification of reporting units, assignment of assets and liabilities to reporting units, and assignment of goodwill to reporting units. If a quantitative impairment test is performed, the fair value of each reporting unit is estimated through the use of a discounted cash flow methodology, which also requires judgment and assumptions, including discount rate, projected future revenues, projected future operating margins, and terminal growth rates. The estimates used to calculate the fair value of a reporting unit change from year to year based on operating results, market conditions, and other factors.
Management concluded that no goodwill associated with any reporting unit is currently at risk of impairment based on quantitative assessments performed in 2023. The Company did not recognize any material goodwill or intangible asset impairment charges in fiscal years 2023, 2022, or 2021.
At December 30, 2023, and December 31, 2022, the Company had intellectual property, customer related intangibles, and other identifiable finite-lived intangible assets recorded at a cost of $553,163 and $511,716, respectively. Identifiable, finite-lived intangible assets are amortized over their estimated useful lives on a straight-line basis typically over three to twelve years. Accumulated amortization was $366,560 and $333,256 at December 30, 2023 and December 31, 2022, respectively. Amortization expense on these intangible assets was $30,513, $30,561, and $35,540 for the years ended December 30, 2023, December 31, 2022, and December 25, 2021, respectively. In the next five years, the amortization expense is estimated to be $30,839, $27,629, $24,425, $20,578, and $15,496, respectively. The Company also reviews finite-lived intangible assets for impairment in accordance with ASC Topic 360, as described above, whenever events or changes in circumstances indicate the carrying amount of an asset or asset group may not be fully recoverable.
Leases
The Company leases certain real estate properties, vehicles, and equipment in various countries around the world. Leased properties are typically used for office space, distribution, and retail. The Company’s leases are classified as operating leases with remaining terms of 1 to 30 years, some of which include an option to extend or renew. If the exercise of an option to extend or renew is determined to be reasonably certain, the associated right-of-use asset and lease liability reflects the extended period and payments. For newly signed leases, the right-of-use asset and lease liability is recognized on lease commencement date. Variable lease costs, such as adjustments to payments based on consumer price indices, are excluded in the recognition of right-of-use assets and lease liabilities. For all real estate leases, any non-lease components, including common area maintenance, have been separated from lease components and excluded from the associated right-of-use asset and lease liability calculations. For all equipment and vehicle leases, an accounting policy election has been made to not separate lease and non-lease components.
Leases with an initial term of 12 months or less (“short-term leases”) are not recognized on the Company’s consolidated balance sheets as a right-of-use asset or lease liability.
Product Warranty
The Company accrues for estimated future warranty costs at the time products are sold. The Company’s standard warranty obligation to retail partners generally provides for a right of return of any product for a full refund in the event that such product is not merchantable, is damaged, or is defective. The Company’s standard warranty obligation to its end-users provides for a period of one to two years from date of shipment while certain aviation, marine, and auto OEM products have a warranty period of two years or more from the date of installation. The Company’s estimates of costs to service its warranty obligations are based on historical experience and management’s expectations and judgments of future conditions, with most claims resolved within a year of the sale. To the extent the Company experiences increased warranty claim activity or increased costs associated with servicing those claims, its warranty accrual will increase, which may result in decreased gross profit. The following reconciliation presents details of the changes in the Company’s accrued warranty costs:
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Balance - beginning of period | $ | 50,952 | $ | 45,467 | $ | 42,643 | ||||||
| Accrual for products sold (1) | 79,637 | 72,821 | 69,810 | |||||||||
| Expenditures | (74,851 | ) | (67,336 | ) | (66,986 | ) | ||||||
| Balance - end of period | $ | 55,738 | $ | 50,952 | $ | 45,467 |
(1) Changes in cost estimates related to pre-existing warranties were not material and aggregated with accruals for new warranty contracts in the ‘accrual for products sold’ line.
Contingencies
In the normal course of business, the Company and its subsidiaries are parties to various legal claims, investigations and complaints, including matters alleging patent infringement and other intellectual property claims. The Company evaluates, on a quarterly and annual basis, developments in legal proceedings, investigations, claims, and other loss contingencies that could affect any required accrual or disclosure or estimate of reasonably possible loss or range of loss. An estimated loss from a loss contingency is accrued by a charge to income if it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. If a range of loss is estimated, and some amount within that range appears to be a better estimate than any other amount within that range, then that amount is accrued. If no amount within the range can be identified as a better estimate than any other amount, the Company accrues the minimum amount in the range.
If an outcome unfavorable to the Company is determined to be probable, but the amount of loss cannot be reasonably estimated or is determined to be reasonably possible, but not probable, the Company discloses the nature of the contingency and an estimate of the possible loss or range of loss or a statement that such an estimate cannot be made. The Company’s aggregate range of reasonably possible losses includes (1) matters where a liability has been accrued and there is a reasonably possible loss in excess of the amount accrued for that liability, and (2) matters where a loss is believed to be reasonably possible, but not probable, and a liability therefore has not been accrued. This aggregate range only represents the Company’s estimate of reasonably possible losses and does not represent the Company’s maximum loss exposure. The assessment regarding whether a loss is probable or reasonably possible, and whether the loss or a range of loss is estimable, often involves a series of complex judgments about future events. In assessing the probability of an outcome in a lawsuit, claim or assessment that could be unfavorable to the Company, the Company considers the following factors, among others: (a) the nature of the litigation, claim, or assessment; (b) the progress of the case; (c) the opinions or views of legal counsel and other advisers; (d) the Company's experience in similar cases; (e) the experience of other entities in similar cases; and (f) how the Company intends to respond to the lawsuit, claim, or assessment. Costs incurred in defending lawsuits, claims or assessments are expensed as incurred.
See Note 7 of the Notes to Consolidated Financial Statements for additional information on contingencies.
Recently Adopted Accounting Standards
There are no recently adopted accounting standards that have a material impact on the Company’s consolidated financial statements, accounting policies, processes, or systems.
Recently Issued Accounting Pronouncements Not Yet Adopted
Income Taxes
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”) to enhance the transparency and decision usefulness of income tax disclosures, primarily related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact that the updated standard will have on its financial statement disclosures.
Segment Reporting
In November 2023, the FASB issued Accounting Standards Update No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact that the updated standard will have on its financial statement disclosures.
2. Revenue
In order to further depict how the nature, amount, timing and uncertainty of the Company's revenue and cash flows are affected by economic factors, the Company disaggregates revenue (or “net sales”) by geographic region, major product category, and pattern of recognition.
Disaggregated revenue by geographic region (Americas, APAC, and EMEA) is presented in Note 11 – Segment Information and Geographic Data. Note 11 also contains disaggregated revenue information of the five major product categories identified by the Company – fitness, outdoor, aviation, marine, and auto OEM.
A large majority of the Company’s sales are recognized on a point in time basis, usually once the product is shipped and title and risk of loss have transferred to the customer. Sales recognized over a period of time are primarily within the outdoor, aviation, and auto OEM segments and relate to performance obligations that are satisfied over the estimated life of the product or contractual service period. Revenue disaggregated by the timing of transfer of the goods or services is presented in the table below:
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Point in time | $ | 4,938,479 | $ | 4,602,636 | $ | 4,762,260 | ||||||
| Over time | 289,773 | 257,650 | 220,535 | |||||||||
| Net sales | $ | 5,228,252 | $ | 4,860,286 | $ | 4,982,795 |
Transaction price and costs associated with the Company’s unsatisfied performance obligations are reflected as deferred revenue and deferred costs, respectively, on the Company’s consolidated balance sheets. Such amounts are recognized ratably over the applicable service period or estimated useful life. Changes in deferred revenue and costs during the 52-week period ending December 30, 2023 and 53-week period ending December 31, 2022, are presented below:
| Fiscal Year Ended | ||||||||||||||||
| December 30, 2023 | December 31, 2022 | |||||||||||||||
| Deferred Revenue (1) | Deferred Costs (2) | Deferred Revenue (1) | Deferred Costs (2) | |||||||||||||
| Balance, beginning of period | $ | 126,794 | $ | 24,693 | $ | 129,272 | $ | 28,322 | ||||||||
| Deferrals in period | 300,316 | 24,286 | 255,172 | 17,169 | ||||||||||||
| Recognition of deferrals in period | (289,773 | ) | (21,606 | ) | (257,650 | ) | (20,798 | ) | ||||||||
| Balance, end of period | $ | 137,337 | $ | 27,373 | $ | 126,794 | $ | 24,693 |
(1) Deferred revenue is comprised of both deferred revenue and noncurrent deferred revenue per the consolidated balance sheets.
(2) Deferred costs are comprised of both deferred costs and noncurrent deferred costs per the consolidated balance sheets.
Of the $289,773 of deferred revenue recognized in the 52-weeks ended December 30, 2023, $87,131 was deferred as of the beginning of the period. Of the $257,650 of deferred revenue recognized in the 53-weeks ended December 31, 2022, $84,227 was deferred as of the beginning of the period. Of the $137,337 of deferred revenue as of December 30, 2023, the Company expects to recognize approximately eighty-five percent ratably over a total period of three years or less.
3. Earnings Per Share
The following table sets forth the computation of basic and diluted net income per share. Stock options, stock appreciation rights, and restricted stock units are collectively referred to as "equity awards".
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Numerator: | ||||||||||||
| Numerator for basic and diluted net income per share - net income | $ | 1,289,636 | $ | 973,585 | $ | 1,082,200 | ||||||
| Denominator (in thousands): | ||||||||||||
| Denominator for basic net income per share – weighted-average common shares | 191,397 | 192,544 | 192,180 | |||||||||
| Effect of dilutive equity awards | 661 | 498 | 863 | |||||||||
| Denominator for diluted net income per share – adjusted weighted-average common shares | 192,058 | 193,042 | 193,043 | |||||||||
| Basic net income per share | $ | 6.74 | $ | 5.06 | $ | 5.63 | ||||||
| Diluted net income per share | $ | 6.71 | $ | 5.04 | $ | 5.61 | ||||||
| Shares excluded from diluted net income per share calculation: Anti-dilutive equity awards (in thousands) | - | 625 | 235 |
4. Marketable Securities
ASC Topic 820, Fair Value Measurements and Disclosures, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The accounting guidance classifies the inputs used to measure fair value into the following hierarchy:
| Level 1 | Unadjusted quoted prices in active markets for the identical asset or liability |
| Level 2 | Observable inputs for the asset or liability, either directly or indirectly, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability |
| Level 3 | Unobservable inputs for the asset or liability |
The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Valuation is based on prices obtained from an independent pricing vendor using both market and income approaches. The primary inputs to the valuation include quoted prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields, and credit spreads.
The method described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
Marketable securities classified as available-for-sale securities are summarized below:
| Available-For-Sale Securities as of December 30, 2023 | ||||||||||||||||||
| Fair Value Level | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||||||
| U.S. Treasury securities | Level 2 | $ | 2,971 | $ | 1 | $ | — | $ | 2,972 | |||||||||
| Agency securities | Level 2 | 23,692 | 32 | (585 | ) | 23,139 | ||||||||||||
| Mortgage-backed securities | Level 2 | 38,743 | — | (4,731 | ) | 34,012 | ||||||||||||
| Corporate debt securities | Level 2 | 1,104,834 | 1,680 | (46,073 | ) | 1,060,441 | ||||||||||||
| Municipal securities | Level 2 | 294,240 | 98 | (18,430 | ) | 275,908 | ||||||||||||
| Other | Level 2 | 3,760 | — | (423 | ) | 3,337 | ||||||||||||
| Total | $ | 1,468,240 | $ | 1,811 | $ | **(**70,242 | ) | $ | 1,399,809 |
| Available-For-Sale Securities as of December 31, 2022 | ||||||||||||||||||
| Fair Value Level | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||||||
| U.S. Treasury securities | Level 2 | $ | — | $ | — | $ | — | $ | — | |||||||||
| Agency securities | Level 2 | 7,000 | — | (786 | ) | 6,214 | ||||||||||||
| Mortgage-backed securities | Level 2 | 45,373 | — | (4,525 | ) | 40,848 | ||||||||||||
| Corporate debt securities | Level 2 | 1,106,688 | 188 | (77,802 | ) | 1,029,074 | ||||||||||||
| Municipal securities | Level 2 | 326,058 | 3 | (28,861 | ) | 297,200 | ||||||||||||
| Other | Level 2 | 10,466 | — | (2,154 | ) | 8,312 | ||||||||||||
| Total | $ | 1,495,585 | $ | 191 | $ | **(**114,128 | ) | $ | 1,381,648 |
The primary objectives of the Company’s investment policy are to preserve capital, maintain an acceptable degree of liquidity, and maximize yield within the constraint of low credit risk. The fair value of securities varies from period to period due to changes in interest rates, the performance of the underlying collateral, and the credit performance of the underlying issuer, among other factors.
Accrued interest receivable, which totaled $11,716 as of December 30, 2023, is excluded from both the fair value and amortized cost basis of available-for-sale securities and is included within prepaid expenses and other current assets on the Company’s consolidated balance sheets. The Company writes off impaired accrued interest on a timely basis, generally within 30 days of the due date, by reversing interest income. No accrued interest was written off during the 52-week period ended December 30, 2023.
The Company recognizes impairments relating to credit losses of available-for-sale securities through an allowance for credit losses and other income (expense) on the Company’s consolidated statements of income. Impairment not relating to credit losses is recorded in accumulated other comprehensive income (loss) on the Company’s consolidated balance sheets. The cost of securities sold is based on the specific identification method. Approximately 92% of securities in the Company's portfolio were at an unrealized loss position at December 30, 2023.
The following tables display additional information regarding gross unrealized losses and fair value by major security type for available-for-sale securities in an unrealized loss position as of December 30, 2023 and December 31, 2022.
| As of December 30, 2023 | ||||||||||||||||||||||||
| Less than 12 Consecutive Months | 12 Consecutive Months or Longer | Total | ||||||||||||||||||||||
| Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | |||||||||||||||||||
| U.S. Treasury securities | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||
| Agency securities | (31 | ) | 10,923 | (554 | ) | 6,446 | (585 | ) | 17,369 | |||||||||||||||
| Mortgage-backed securities | — | — | (4,731 | ) | 34,012 | (4,731 | ) | 34,012 | ||||||||||||||||
| Corporate debt securities | (702 | ) | 64,637 | (45,371 | ) | 889,785 | (46,073 | ) | 954,422 | |||||||||||||||
| Municipal securities | (32 | ) | 2,654 | (18,398 | ) | 261,651 | (18,430 | ) | 264,305 | |||||||||||||||
| Other | — | — | (423 | ) | 3,337 | (423 | ) | 3,337 | ||||||||||||||||
| Total | $ | **(**765 | ) | $ | 78,214 | $ | **(**69,477 | ) | $ | 1,195,231 | $ | **(**70,242 | ) | $ | 1,273,445 |
| As of December 31, 2022 | ||||||||||||||||||||||||
| Less than 12 Consecutive Months | 12 Consecutive Months or Longer | Total | ||||||||||||||||||||||
| Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | |||||||||||||||||||
| U.S. Treasury securities | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||
| Agency securities | — | — | (786 | ) | 6,214 | (786 | ) | 6,214 | ||||||||||||||||
| Mortgage-backed securities | (1,900 | ) | 23,229 | (2,625 | ) | 17,619 | (4,525 | ) | 40,848 | |||||||||||||||
| Corporate debt securities | (26,680 | ) | 508,956 | (51,122 | ) | 498,834 | (77,802 | ) | 1,007,790 | |||||||||||||||
| Municipal securities | (2,136 | ) | 69,017 | (26,725 | ) | 225,679 | (28,861 | ) | 294,696 | |||||||||||||||
| Other | — | — | (2,154 | ) | 8,067 | (2,154 | ) | 8,067 | ||||||||||||||||
| Total | $ | **(**30,716 | ) | $ | 601,202 | $ | **(**83,412 | ) | $ | 756,413 | $ | **(**114,128 | ) | $ | 1,357,615 |
As of December 30, 2023 and December 31, 2022, the Company had not recognized an allowance for credit losses on any securities in an unrealized loss position.
The Company has not recorded an allowance for credit losses and charge to other income for the unrealized losses on agency, mortgage-backed, corporate debt, municipal, and other securities presented above because the Company does not consider the declines in fair value to have resulted from credit losses. The Company has not observed a significant deterioration in credit quality of these securities, which are highly rated with moderate to low credit risk. Declines in value are largely attributable to current global economic conditions. The securities continue to make timely principal and interest payments, and the fair values are expected to recover as they approach maturity. The Company does not intend to sell the securities, and it is not more likely than not that the Company will be required to sell the securities, before the respective recoveries of their amortized cost bases, which may be maturity.
The amortized cost and fair value of marketable securities at December 30, 2023, by maturity, are shown below.
| Amortized Cost | Fair Value | |||||||
| Due in one year or less | $ | 279,137 | $ | 274,618 | ||||
| Due after one year through five years | 1,170,760 | 1,109,093 | ||||||
| Due after five years through ten years | 10,067 | 9,187 | ||||||
| Due after ten years | 8,276 | 6,911 | ||||||
| Total | $ | 1,468,240 | $ | 1,399,809 |
5. Income Taxes
The Company’s income tax provision (benefit) consists of the following:
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| U.S. federal: | ||||||||||||
| Current | $ | 25,985 | $ | 45,639 | $ | (13,096 | ) | |||||
| Deferred | (122,291 | ) | (149,734 | ) | (42,625 | ) | ||||||
| $ | (96,306 | ) | $ | (104,095 | ) | $ | (55,721 | ) | ||||
| U.S. state: | ||||||||||||
| Current | $ | 6,755 | $ | 12,870 | $ | (5,876 | ) | |||||
| Deferred | (26,602 | ) | (29,160 | ) | (8,132 | ) | ||||||
| $ | (19,847 | ) | $ | (16,290 | ) | $ | (14,008 | ) | ||||
| Foreign: | ||||||||||||
| Current | $ | 217,706 | $ | 175,335 | $ | 149,012 | ||||||
| Deferred | (190,833 | ) | 36,439 | 45,313 | ||||||||
| $ | 26,873 | $ | 211,774 | $ | 194,325 | |||||||
| Total | $ | (89,280 | ) | $ | 91,389 | $ | 124,596 |
The income tax provision differs from the amount computed by applying the U.S. statutory federal income tax rate to income before taxes. The sources and tax effects of the differences, including the impact of establishing tax contingency accruals, are as follows:
| Fiscal Year Ended | ||||||||||||
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Federal income tax expense at U.S. statutory rate | $ | 252,095 | $ | 223,658 | $ | 253,429 | ||||||
| State income tax (benefit) expense, net of federal tax effect | (23,045 | ) | (21,064 | ) | (12,198 | ) | ||||||
| Foreign-derived intangible income (FDII) deduction | (6,432 | ) | (12,343 | ) | — | |||||||
| Foreign tax rate differential | (129,733 | ) | (114,599 | ) | (117,586 | ) | ||||||
| Other foreign taxes, net of incentives and credits | 18,351 | 24,273 | 29,240 | |||||||||
| Withholding tax | 24,497 | 27,041 | 22,992 | |||||||||
| Net change in uncertain tax positions | (13,157 | ) | (14,381 | ) | (17,087 | ) | ||||||
| U.S. federal research and development credit | (31,849 | ) | (29,384 | ) | (22,764 | ) | ||||||
| Stock-based compensation | (851 | ) | 30 | (6,362 | ) | |||||||
| Switzerland deferred tax assets | (181,410 | ) | 7,168 | (177 | ) | |||||||
| Other, net | 2,254 | 990 | (4,891 | ) | ||||||||
| Income tax expense | $ | (89,280 | ) | $ | 91,389 | $ | 124,596 |
The Company recorded income tax benefit of $89,280 in the year ended December 30, 2023, representing an effective tax rate of approximately (7%), which included income tax benefit of $181,410 recognized by the Company in the fourth quarter of 2023 related to the revaluation of Switzerland deferred tax assets due to an increase in the Schaffhausen cantonal tax rate and income tax benefit of $12,116 recognized in the fourth quarter of 2023 related to Auto OEM manufacturing tax incentives in Poland. The Company recorded income tax expense of $91,389 in the year ended December 31, 2022, representing an effective tax rate of approximately 9%, which included income tax expense of $7,168 recognized by the Company in the fourth quarter of 2022 related to the revaluation of Switzerland deferred tax assets. The Company recorded income tax expense of $124,596 in the year ended December 25, 2021.
The Company’s statutory federal and cantonal income tax rate in Switzerland, the Company's place of incorporation, was approximately 14% in fiscal years 2023, 2022, and 2021. If the Company reconciled taxes at the Swiss holding company federal statutory tax rate to the reported income tax expense for 2023 as presented above, the amounts related to tax at the statutory rate would be approximately $86,000 lower, or $166,000, and the foreign tax rate differential would be adjusted by a similar amount to approximately $38,000. For 2022, the amounts related to tax at the statutory rate would be approximately $77,000 lower, or $147,000, and the foreign tax rate differential would be adjusted by a similar amount to approximately $33,000. For 2021, the amounts related to tax at the statutory rate would be approximately $84,000 lower, or $169,000, and the foreign tax rate differential would be adjusted by a similar amount to approximately $28,000. All other amounts would remain substantially unchanged.
The Company’s income before income taxes attributable to non-U.S. operations was $1,406,916, $1,287,794, and $1,227,666, for the years ended December 30, 2023, December 31, 2022, and December 25, 2021, respectively.
Income taxes of $42,015, $45,459, and $50,127 at December 30, 2023, December 31, 2022, and December 25, 2021, respectively, have not been accrued by the Company for the unremitted earnings of several of its foreign subsidiaries because such earnings are intended to be reinvested in the subsidiaries indefinitely.
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows:
| December 30, 2023 | December 31, 2022 | |||||||
| Deferred tax assets: | ||||||||
| Capitalized research & development expenses | $ | 385,916 | $ | 231,429 | ||||
| Intangible assets | 321,500 | 156,702 | ||||||
| Tax credit carryforwards | 33,527 | 19,950 | ||||||
| Operating leases | 27,987 | 30,310 | ||||||
| Tax basis in excess of book basis for investments | 18,939 | 27,227 | ||||||
| Deferred revenue | 17,815 | 18,327 | ||||||
| Net operating losses | 16,066 | 4,955 | ||||||
| Accrued paid time off | 15,591 | 14,986 | ||||||
| Product warranty accruals | 12,631 | 12,111 | ||||||
| Stock-based compensation | 10,880 | 8,667 | ||||||
| Other | 25,231 | 18,259 | ||||||
| Valuation allowance related to loss carryforward and tax credits | (12,870 | ) | (17,077 | ) | ||||
| $ | 873,213 | $ | 525,846 | |||||
| Deferred tax liabilities: | ||||||||
| Withholding tax | 107,352 | 108,692 | ||||||
| Property and equipment | 68,557 | 40,526 | ||||||
| Operating leases | 27,432 | 29,756 | ||||||
| Book basis in excess of tax basis for acquired entities | 18,596 | 21,970 | ||||||
| Prepaid and perpetual license assets | 10,051 | 11,798 | ||||||
| Other | 1,272 | 1,998 | ||||||
| $ | 233,260 | $ | 214,740 | |||||
| Net deferred tax assets | $ | 639,953 | $ | 311,106 |
Deferred taxes related to intangible assets increased by $164,798 as of December 30, 2023 as compared to December 31, 2022, primarily related to the revaluation of Switzerland deferred tax assets recognized in the fourth quarter of 2023. Deferred tax assets related to capitalized research and development expenses increased by $154,487 as of December 30, 2023 as compared to December 31, 2022, primarily related to the 2017 United States Tax Cuts and Jobs Act, which included provisions that became effective during 2022 tax year that require the Company to capitalize certain research and development costs and amortize those capitalized costs on its U.S. tax returns over a period of five or fifteen years, depending on where the associated costs were incurred.
At December 30, 2023, the Company had $33,527 of tax credit carryover compared to $19,950 at December 31, 2022. At December 30, 2023, the Company had a deferred tax asset of $16,066 related to the future tax benefit of net operating loss (NOL) carryforwards of $55,524. Included in the NOL carryforwards is $8,319 that relates to various jurisdictions and expires in periods ranging from 2025 through 2037 and $47,205 that relates to various other jurisdictions and has no expiration date. The Company has recorded a valuation allowance for a portion of its deferred tax asset relating to various tax attributes that management does not believe are more likely than not to be realized. In the future, if the Company determines, based on existence of sufficient evidence, that it should realize more or less of its deferred tax assets, an adjustment to the valuation allowance will be made in the period such a determination is made.
The total amount of gross unrecognized tax benefits as of December 30, 2023 was $13,571. A reconciliation of the beginning and ending amount of gross unrecognized tax benefits for years ended December 30, 2023, December 31, 2022, and December 25, 2021 is as follows:
| December 30, 2023 | December 31, 2022 | December 25, 2021 | ||||||||||
| Balance beginning of year | $ | 30,795 | $ | 65,216 | $ | 84,985 | ||||||
| Additions based on tax positions related to prior years | — | — | — | |||||||||
| Reductions based on tax positions related to prior years | (3,450 | ) | (6,363 | ) | (4,727 | ) | ||||||
| Additions based on tax positions related to current period | 450 | 2,368 | 4,272 | |||||||||
| Reductions related to settlements with tax authorities | — | (15,476 | ) | — | ||||||||
| Expiration of statute of limitations | (14,224 | ) | (14,950 | ) | (19,314 | ) | ||||||
| Balance at end of year | $ | 13,571 | $ | 30,795 | $ | 65,216 |
Accounting guidance requires unrecognized tax benefits to be classified as noncurrent liabilities, except for the portion that is expected to be paid within one year of the balance sheet date. The balance of net unrecognized benefits of $12,824, $29,159, and $54,443 are classified as noncurrent at December 30, 2023, December 31, 2022, and December 25, 2021, respectively. The net unrecognized tax benefits, if recognized, would reduce the effective tax rate. None of the unrecognized tax benefits are due to uncertainty in the timing of deductibility.
Interest and penalties, if any, accrued on the unrecognized tax benefits are reflected in income tax expense. At December 30, 2023, December 31, 2022, and December 25, 2021, the Company had accrued approximately $2,127, $2,751, and $4,255, respectively, for interest. The interest component of the reserve decreased income tax expense for the years ending December 30, 2023, December 31, 2022, and December 25, 2021 by $624, $1,474, and $1,441, respectively. The Company did not have significant amounts accrued for penalties for the years ending December 30, 2023, December 31, 2022, and December 25, 2021.
The Company files income tax returns in Switzerland, Taiwan, United Kingdom, U.S. federal jurisdiction, as well as various states, local, and other foreign jurisdictions. In its major tax jurisdictions, Switzerland, Taiwan, United Kingdom, and U.S. federal and various states, the Company is no longer subject to income tax examinations by tax authorities, with few exceptions, for years prior to 2019, 2018, 2021, and 2020, respectively.
The Company recognized a reduction of income tax expense, inclusive of interest and net of deferrals, of $11,473, $12,749, and $22,221 in fiscal years ended December 30, 2023, December 31, 2022, and December 25, 2021, respectively, to reflect the expiration of statutes of limitations and releases due to audit settlement in various jurisdictions.
The Company believes that it is reasonably possible that approximately $3,000 to $7,000 of its reserves for certain unrecognized tax benefits will decrease within the next 12 months as the result of the expiration of statutes of limitations. This potential decrease in unrecognized tax benefits would impact the Company’s effective tax rate within the next 12 months.
6. Leases
The following table represents lease costs recognized in the Company’s consolidated statements of income for the 52-weeks ended December 30, 2023. Lease costs are included in selling, general and administrative expense and research and development expense on the Company’s consolidated statements of income.
| Fiscal Year Ended | ||||||||
| December 30, 2023 | December 31, 2022 | |||||||
| Operating lease cost (1) | $ | 47,331 | $ | 40,679 |
(1) Operating lease cost includes short-term lease costs and variable lease costs, which were not material in the period presented.
The following table represents the components of leases that are recognized on the Company’s consolidated balance sheets as of December 30, 2023 and December 31, 2022.
| December 30, 2023 | December 31, 2022 | |||||||
| Operating lease right-of-use assets | $ | 143,724 | $ | 138,040 | ||||
| Other accrued expenses | $ | 27,776 | $ | 25,149 | ||||
| Noncurrent operating lease liabilities | 113,035 | 114,541 | ||||||
| Total lease liabilities | $ | 140,811 | $ | 139,690 | ||||
| Weighted average remaining lease term | 6.6 years | 7.3 years | ||||||
| Weighted average discount rate | 3.8 | % | 3.3 | % |
The following table represents the maturity of lease liabilities.
| Year | Amount | |||
| 2024 | $ | 34,693 | ||
| 2025 | 28,830 | |||
| 2026 | 21,772 | |||
| 2027 | 17,167 | |||
| 2028 | 15,513 | |||
| Thereafter | 45,301 | |||
| Total | 163,276 | |||
| Less: imputed interest | (22,465 | ) | ||
| Present value of lease liabilities | 140,811 |
The following table presents supplemental cash flow and noncash information related to leases.
| Fiscal Year Ended | ||||||||
| December 30, 2023 | December 31, 2022 | |||||||
| Cash paid for amounts included in the measurement of operating lease liabilities (1) | $ | 34,602 | $ | 28,714 | ||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | $ | 18,520 | $ | 68,188 |
(1) Included in net cash provided by operating activities on the Company's statements of cash flows
7. Commitments and Contingencies
Commitments
The Company is party to certain commitments that require the future purchase of goods or services (“unconditional purchase obligations”). The Company’s unconditional purchase obligations primarily consist of payments for inventory, capital expenditures, and other indirect purchases in connection with conducting the business. The aggregate amount of purchase orders and other commitments open as of December 30, 2023 that may represent noncancellable unconditional purchase obligations having a remaining term in excess of one year was approximately $274,000.
Certain cash balances are held as collateral in relation to bank guarantees. The total amount of restricted cash was $704 and $718 on December 30, 2023 and December 31, 2022, respectively.
Contingencies
Management of the Company currently does not believe it is reasonably possible that the Company may have incurred a material loss, or a material loss in excess of recorded accruals, with respect to loss contingencies in the aggregate, for the fiscal year ended December 30, 2023. The results of legal proceedings, investigations and claims, however, cannot be predicted with certainty. An adverse resolution of one or more of such matters in excess of management’s expectations could have a material adverse effect in the particular quarter or fiscal year in which a loss is recorded, but based on information currently known, the Company does not believe it is likely that losses from such matters would have a material adverse effect on the Company’s business or its consolidated financial position, results of operations or cash flows.
The Company settled or resolved certain legal matters during the fiscal years ended December 30, 2023, December 31, 2022, and December 25, 2021 that did not individually or in the aggregate have a material impact on the Company’s business or its consolidated financial position, results of operations or cash flows.
8. Stockholders' Equity
Dividends
Under Swiss corporate law, dividends must be approved by shareholders at the annual general meeting of the Company’s shareholders. Approved dividends are subject to possible adjustment based on the total amount of the dividend in Swiss Francs as approved at the annual meeting, and are payable in four equal installments on dates determined by the Board of Directors. A reduction of retained earnings and a corresponding liability are recorded at the time of shareholders' approval and are periodically adjusted based on the number of applicable shares outstanding.
The Company's shareholders approved the following dividends:
| Declaration Date | Dividend Date | Record Date | Dividend Per Share | Payment Amount | ||||||||
| Fiscal 2023 | ||||||||||||
| June 9, 2023 | June 30, 2023 | June 20, 2023 | $ | 0.73 | $ | 139,595 | ||||||
| June 9, 2023 | September 29, 2023 | September 15, 2023 | $ | 0.73 | $ | 139,724 | ||||||
| June 9, 2023 | December 29, 2023 | December 15, 2023 | $ | 0.73 | $ | 139,603 | ||||||
| June 9, 2023 | March 29, 2024 | March 15, 2024 | $ | 0.73 | $ | 139,997 | ||||||
| Total | $ | 2.92 | $ | 558,919 | ||||||||
| Fiscal 2022 | ||||||||||||
| June 10, 2022 | June 30, 2022 | June 20, 2022 | $ | 0.73 | $ | 140,825 | ||||||
| June 10, 2022 | September 30, 2022 | September 15, 2022 | $ | 0.73 | $ | 140,413 | ||||||
| June 10, 2022 | December 30, 2022 | December 15, 2022 | $ | 0.73 | $ | 139,610 | ||||||
| June 10, 2022 | March 31, 2023 | March 15, 2023 | $ | 0.73 | $ | 139,847 | ||||||
| Total | $ | 2.92 | $ | 560,695 | ||||||||
| Fiscal 2021 | ||||||||||||
| June 4, 2021 | June 30, 2021 | June 15, 2021 | $ | 0.67 | $ | 128,741 | ||||||
| June 4, 2021 | September 30, 2021 | September 15, 2021 | $ | 0.67 | $ | 128,856 | ||||||
| June 4, 2021 | December 31, 2021 | December 15, 2021 | $ | 0.67 | $ | 128,856 | ||||||
| June 4, 2021 | March 31, 2022 | March 15, 2022 | $ | 0.67 | $ | 129,394 | ||||||
| Total | $ | 2.68 | $ | 515,846 |
The estimated payment amount for the dividend scheduled to be paid on March 29, 2024 was included in dividend payable on the Company’s consolidated balance sheets as of December 30, 2023. Approximately $61,129 of retained earnings was indefinitely restricted from distribution to shareholders pursuant to the laws of Taiwan as of December 30, 2023 and December 31, 2022.
Share Repurchase Program
On April 22, 2022, the Board of Directors approved a share repurchase program (the “2022 Program”) authorizing the Company to repurchase up to $300,000 of the common shares of Garmin Ltd., exclusive of the cost of any associated excise tax. As of December 30, 2023, the Company had repurchased 3,176,453 shares for $300,000, leaving $0 available to repurchase additional shares under the 2022 Program when the share repurchase authorization expired on December 29, 2023. Cash paid for purchases of the Company’s shares during fiscal 2023 was $98,988.
On February 16, 2024, the Board of Directors approved a share repurchase program (the “2024 Program”) authorizing the Company to repurchase up to $300,000 of the common shares of Garmin Ltd., exclusive of the cost of any associated excise tax. The timing and volume of share repurchases are subject to market conditions, business conditions and applicable laws, and are at management’s discretion. Share repurchases may be made from time to time in the open market or in privately negotiated transactions, including under plans complying with the provisions of Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The 2024 Program does not require the purchase of any minimum number of shares and may be suspended or discontinued at any time. The share repurchase authorization expires on December 26, 2026.
Share Capital
In the second quarter of 2023, the share capital currency of the Company was changed from the Swiss Franc (CHF) to the U.S. Dollar (USD), as approved by shareholders at the Company’s 2023 Annual General Meeting. This aligns the share capital currency with the financial statement presentation currency of the Company. The Company’s nominal par value per share of CHF 0.10 was slightly reduced to USD $0.10, the impact of which is reflected in share capital, captioned as common shares on the Company’s consolidated balance sheets. Total stockholders’ equity reported for the Company was not affected by this change. The Company's common shares had a par value of USD $0.10 and CHF 0.10 per share as of December 30, 2023 and December 31, 2022, respectively.
Treasury Shares
In June 2023, the Company's shareholders approved the cancellation of 2,196,990 shares previously purchased under its share repurchase program. The capital reduction by cancellation of these shares became effective in June 2023. Total stockholders’ equity reported for the Company was not affected.
9. Accumulated Other Comprehensive Income (Loss)
The following provides required disclosure of changes in accumulated other comprehensive income (loss) balances by component for the year ended December 30, 2023:
| Foreign currency translation adjustment | Net gains (losses) on available-for-sale securities | Total | ||||||||||
| Balance - beginning of period | $ | (25,981 | ) | $ | (88,552 | ) | $ | (114,533 | ) | |||
| Other comprehensive income (loss) before reclassification, net of income tax expense of $11,046 | 14,473 | 34,398 | 48,871 | |||||||||
| Amounts reclassified from accumulated other comprehensive income (loss) to other income (expense), net of income tax benefit of $14 included in income tax provision | — | 48 | 48 | |||||||||
| Net current-period other comprehensive income (loss) | 14,473 | 34,446 | 48,919 | |||||||||
| Balance - end of period | $ | (11,508 | ) | $ | (54,106 | ) | $ | (65,614 | ) |
10. Employee Stock Compensation and Savings Plans
Stock Compensation
The various Company stock compensation plans are summarized below. For all stock compensation plans, the Company’s policy is to issue treasury shares for option/stock appreciation right (SAR) exercises, restricted stock unit (RSU) releases, and employee stock purchase plan (ESPP) purchases.
2011 Non-employee Directors’ Equity Incentive Plan
In June 2011, the shareholders adopted an equity incentive plan for non-employee directors (the “2011 Directors Plan”) providing for grants of stock options, SARs, RSUs and/or performance shares, pursuant to which up to 122,592 shares were made available for issuance. In June 2023, the shareholders approved an increase to the number of shares authorized to 150,000. The term of each award cannot exceed ten years. Awards are subject to a minimum one-year vesting period. In 2023, 2022, and 2021, there were 6,004, 6,008, and 4,180 RSUs granted under this plan, respectively. At December 30, 2023, approximately 33,400 shares were available for future issuance under the 2011 Directors Plan.
2005 Equity Incentive Plan
In June 2005, the shareholders adopted an equity incentive plan (the “2005 Plan”) providing for grants of incentive and nonqualified stock options, SARs, RSUs and/or performance shares to employees of the Company and its subsidiaries, pursuant to which up to 10,000,000 common shares were made available for issuance. In 2013, the shareholders approved an increase of an additional 3,000,000 shares to the 2005 Plan, making the total shares authorized under the plan 13,000,000. Option and SAR grants vest evenly over a period of five years or as otherwise determined by the Board of Directors or the Compensation Committee and generally expire ten years from the date of grant, if not exercised. RSUs vest evenly over a period of three years. In addition to time-based vesting requirements, the vesting of certain RSU grants is also contingent upon the Company’s achievement of certain financial performance goals. During 2023, 2022, and 2021, there were 1,047,934, 1,185,707, and 866,614 RSUs granted under the 2005 Plan, respectively. No stock options or SARs were granted under the 2005 Plan in 2023, 2022, or 2021. At December 30, 2023, approximately 1,171,977 shares were available for future issuance under the 2005 Plan.
2000 Equity Incentive Plan
In October 2000, the shareholders adopted an equity incentive plan (the “2000 Plan”) providing for grants of incentive and nonqualified stock options, SARs, restricted shares and/or performance shares to employees of the Company and its subsidiaries, pursuant to which up to 7,000,000 common shares were made available for issuance. The stock options and SARs vest evenly over a period of five years or as otherwise determined by the Board of Directors or the Compensation Committee and generally expire ten years from the date of grant, if not exercised. The Company did not grant any stock awards from the 2000 Plan in 2023, 2022, or 2021. In February 2023, the Board of Directors approved the termination of the 2000 Plan, which was effective immediately.
Stock Compensation Activity
A summary of the Company’s stock compensation activity and related information under the 2011 Directors Plan, the 2005 Plan, and the 2000 Plan for the years ended December 30, 2023, December 31, 2022, and December 25, 2021 is provided below:
| Stock Options and SARs | ||||||||
| Weighted-Average Exercise Price | Number of Shares | |||||||
| (In Thousands) | ||||||||
| Outstanding at December 26, 2020 | $ | 52.44 | 13 | |||||
| Granted | — | |||||||
| Exercised | $ | 52.44 | (13 | ) | ||||
| Forfeited/Expired | — | |||||||
| Outstanding at December 25, 2021 | — | |||||||
| Granted | — | |||||||
| Exercised | — | |||||||
| Forfeited/Expired | — | |||||||
| Outstanding at December 31, 2022 | — | |||||||
| Granted | — | |||||||
| Exercised | — | |||||||
| Forfeited/Expired | — | |||||||
| Outstanding at December 30, 2023 | — | |||||||
| Exercisable at December 30, 2023 | — | |||||||
| Expected to vest after December 30, 2023 | — |
| Restricted Stock Units | ||||||||
| Weighted-Average Grant Date Fair Value | Number of Shares | |||||||
| (In Thousands) | ||||||||
| Outstanding at December 26, 2020 | $ | 86.98 | 1,582 | |||||
| Granted | $ | 116.40 | 871 | |||||
| Released/Vested | $ | 80.12 | (884 | ) | ||||
| Cancelled | $ | 95.79 | (56 | ) | ||||
| Outstanding at December 25, 2021 | $ | 107.60 | 1,513 | |||||
| Granted | $ | 98.39 | 1,192 | |||||
| Released/Vested | $ | 102.80 | (805 | ) | ||||
| Cancelled | $ | 111.12 | (63 | ) | ||||
| Outstanding at December 31, 2022 | $ | 103.61 | 1,837 | |||||
| Granted | $ | 105.47 | 1,054 | |||||
| Released/Vested | $ | 103.61 | (749 | ) | ||||
| Cancelled | $ | 106.09 | (456 | ) | ||||
| Outstanding at December 30, 2023 | $ | 104.10 | 1,686 |
The weighted-average remaining contract life of restricted stock units at December 30, 2023 was 1.36 years.
The total fair value of awards vested during 2023, 2022, and 2021, was $77,626, $82,734, and $70,796, respectively. The aggregate intrinsic values of options and SARs exercised during 2023, 2022, and 2021 were $0, $0, and $1,040, respectively. The aggregate intrinsic value of RSUs outstanding at December 30, 2023 was $216,667. The aggregate intrinsic values of RSUs released during 2023, 2022, and 2021 were $96,301, $74,278, and $118,825, respectively. Aggregate intrinsic value of options and SARs represents the applicable number of awards multiplied by the positive difference between the exercise price and the Company’s closing share price on the last trading day of the relevant fiscal period. Aggregate intrinsic value of RSUs represents the applicable number of awards multiplied by the Company’s closing share price on the last trading day of the relevant fiscal period. The Company’s closing share price was $128.54 on December 30, 2023 (based on the closing share price on December 29, 2023). As of December 30, 2023, there was $133,648 of total unrecognized compensation cost related to unvested stock-based compensation awards granted to employees under the stock compensation plans. That cost is expected to be recognized over the remaining vesting period.
Employee Stock Purchase Plan
The shareholders have adopted an ESPP. Up to 10,000,000 common shares have been reserved for the ESPP. Shares are offered to employees at a price equal to the lesser of 85% of the fair market value of the Company's shares on the date of purchase or 85% of the fair market value on the first day of the ESPP period. The ESPP is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code. During 2023, 2022, and 2021, there were 524,774, 687,370, and 385,211 shares purchased under the plan for a total purchase price of $43,905, $62,154, and $34,936, respectively. During 2023, 2022, and 2021, the purchases were issued from treasury shares. At December 30, 2023, approximately 2,262,760 shares were available for future issuance under the ESPP.
Savings Plans
Certain subsidiaries of the Company sponsor various defined contribution employee retirement plans. GII and the Company’s other U.S.-based subsidiaries sponsor a plan under which their employees may contribute up to 50% of their annual compensation subject to Internal Revenue Code maximum limitations and to which the subsidiaries contribute a specified percentage of each participant’s annual compensation up to certain limits as defined in the retirement plan. During the years ended December 30, 2023, December 31, 2022, and December 25, 2021, expense related to this and other defined contribution plans of $84,609, $80,435, and $71,262, respectively, was recorded within the Company’s consolidated statements of income.
Certain of the Company’s non-U.S. subsidiaries sponsor or participate in local defined benefit pension plans. The obligations, contributions, and associated expense of such plans for the years ended December 30, 2023, December 31, 2022, and December 25, 2021 were not material.
11. Segment Information and Geographic Data
Garmin is organized in the five operating segments of fitness, outdoor, aviation, marine, and auto OEM. These operating segments represent the Company's reportable segments.
The Company’s Chief Executive Officer, who has been identified as the CODM, primarily uses operating income as the measure of profit or loss to assess segment performance and allocate resources. Operating income represents net sales less costs of goods sold and operating expenses. Net sales are directly attributed to each segment. Most costs of goods sold and the majority of operating expenses are also directly attributed to each segment, while certain other costs of goods sold and operating expenses are allocated to the segments in a reasonable manner considering the specific facts and circumstances of the expenses being allocated. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. There are no inter-segment sales or transfers.
The Company’s segments share many common resources, infrastructures and assets in the normal course of business. Thus, the Company does not report accounts receivable, inventories, property and equipment, intangible assets, or capital expenditures by segment to the CODM.
As indicated in Note 1 of the Notes to Consolidated Financial Statements, the Company announced an organization realignment in January 2023, which combined the consumer auto operating segment with the outdoor operating segment. As a result, the Company’s operating segments, which also represent its reportable segments, are fitness, outdoor, aviation, marine, and auto OEM. Results for the 53-week and 52-week periods ended December 31, 2022 and December 25, 2021, respectively, have been recast below to conform with the current period presentation.
Net sales (“revenue”), gross profit, and operating income for each of the Company’s five reportable segments are presented below.
| Fitness | Outdoor | Aviation | Marine | Auto OEM | Total | |||||||||||||||||||
| 52-Weeks Ended December 30, 2023 | ||||||||||||||||||||||||
| Net sales | $ | 1,344,637 | $ | 1,697,151 | $ | 846,329 | $ | 916,911 | $ | 423,224 | $ | 5,228,252 | ||||||||||||
| Gross profit | 716,906 | 1,072,861 | 625,988 | 491,261 | 97,939 | 3,004,955 | ||||||||||||||||||
| Operating income (loss) | 232,201 | 515,254 | 226,400 | 179,429 | (61,124 | ) | 1,092,160 | |||||||||||||||||
| 53-Weeks Ended December 31, 2022 | ||||||||||||||||||||||||
| Net sales | $ | 1,109,419 | $ | 1,770,275 | $ | 792,799 | $ | 903,983 | $ | 283,810 | $ | 4,860,286 | ||||||||||||
| Gross profit | 552,417 | 1,099,408 | 573,063 | 491,457 | 90,430 | 2,806,775 | ||||||||||||||||||
| Operating income (loss) | 104,738 | 573,281 | 213,186 | 215,304 | (78,664 | ) | 1,027,845 | |||||||||||||||||
| 53-Weeks Ended December 25, 2021 | ||||||||||||||||||||||||
| Net sales | $ | 1,533,788 | $ | 1,606,664 | $ | 712,468 | $ | 875,151 | $ | 254,724 | $ | 4,982,795 | ||||||||||||
| Gross profit | 813,325 | 988,662 | 519,821 | 495,310 | 73,341 | 2,890,459 | ||||||||||||||||||
| Operating income (loss) | 359,201 | 524,469 | 193,188 | 249,781 | (108,019 | ) | 1,218,620 |
Net sales, property and equipment, and net assets by geographic area are as shown below for the fiscal years ended December 30, 2023, December 31, 2022, and December 25, 2021. Note that APAC includes Asia Pacific and Australian Continent, and EMEA includes Europe, the Middle East and Africa.
| Americas | EMEA | APAC | Total | |||||||||||||
| December 30, 2023 | ||||||||||||||||
| Net sales to external customers (1) | $ | 2,614,358 | $ | 1,775,965 | $ | 837,929 | $ | 5,228,252 | ||||||||
| Property and equipment, net | 736,218 | 141,388 | 346,491 | 1,224,097 | ||||||||||||
| Net assets (2) | 4,377,450 | 1,297,580 | 1,339,275 | 7,014,305 | ||||||||||||
| December 31, 2022 | ||||||||||||||||
| Net sales to external customers (1) | $ | 2,429,029 | $ | 1,633,640 | $ | 797,617 | $ | 4,860,286 | ||||||||
| Property and equipment, net | 676,855 | 121,920 | 348,230 | 1,147,005 | ||||||||||||
| Net assets (2) | 3,717,198 | 1,210,461 | 1,276,681 | 6,204,340 | ||||||||||||
| December 25, 2021 | ||||||||||||||||
| Net sales to external customers (1) | $ | 2,349,514 | $ | 1,858,908 | $ | 774,373 | $ | 4,982,795 | ||||||||
| Property and equipment, net | 576,481 | 120,004 | 370,993 | 1,067,478 | ||||||||||||
| Net assets (2) | 3,745,120 | 1,227,928 | 1,141,111 | 6,114,159 |
(1) The United States is the only country which constitutes greater than 10% of net sales to external customers.
(2) Americas and APAC net assets are primarily held in the United States and Taiwan, respectively.
Previous: Item 7A. Quantitative and Qualitative Disclosures About Market Risk · Next: Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure